BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20574902)

  • 1. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.
    Hartung T
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):277-90. PubMed ID: 20574902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.
    Locke PA; Bruce Myers D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):376-84. PubMed ID: 20574909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal protection perspective on 21st century toxicology.
    Stephens ML
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):291-8. PubMed ID: 20574903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of toxicity testing.
    Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 12. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
    Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
    Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Waddell WJ
    Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discussion of the impact of US chemical regulation legislation on the field of toxicity testing.
    Sullivan K; Beck N; Sandusky C; Willett C
    Toxicol In Vitro; 2011 Sep; 25(6):1231-6. PubMed ID: 21624455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals.
    Firestone M; Kavlock R; Zenick H; Kramer M;
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):139-62. PubMed ID: 20574895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of alternative methods.
    Goldberg AM
    J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Replacement Methods to Animal Testing" as the incentive topic of the German Ministry of Education and Research. Selected results on biological drugs].
    Diekmann W; Hansper M
    ALTEX; 2001; 18(1):23-8. PubMed ID: 11248846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.